FDA Warning Letter — Peak Performance Peptides
The FDA took a Warning Letter action against Peak Performance Peptides on August 24, 2026 (Phoenix, AZ). The action was issued by CDER and concerns drugs products.
Action Details
- Facility
- Peak Performance Peptides
- Date
- August 24, 2026
- Fiscal Year
- 2026
- Product Type
- Drugs
- Center
- CDER
- Location
- Phoenix, AZ (United States)